Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Gullo, Damiano ^a   Latina, Adele ^a   Frasca, Francesco ^a   Moli, Rosario ^a   Pellegriti, Gabriella ^a   Vigneri, Riccardo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROXINE; THYROTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EUTHYROIDISM; FEEDBACK SYSTEM; FEMALE; HORMONE SYNTHESIS; HUMAN; HYPOTHYROIDISM; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID HORMONE BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; ENZYME IMMUNOASSAY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; HUMANS; HYPOTHYROIDISM; IMMUNOENZYME TECHNIQUES; RETROSPECTIVE STUDIES; THYROID HORMONES; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 79960953366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022552     Document Type: Article

References (31)

1. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr, (1999) Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340: 424-9.
2. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, et al. (2005) Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 90: 2666-74.
3. Woeber KA, (2002) Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 25: 106-9.
4. Iverson JF, Mariash CN, (2008) Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism. Endocr Pract 14: 550-5.
5. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G, (1995) Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest 96: 2828-38.
6. Dayan CM, Panicker V, (2009) Novel insights into thyroid hormones from the study of common genetic variation. Nat Rev Endocrinol 5: 211-8.
7. Meier C, Trittibach P, Guglielmetti M, Staub JJ, Müller B, (2003) Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey. BMJ 326: 311-2.
8. Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ, (1997) Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 82: 771-6.
9. Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA, (2005) TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr 117: 636-40.
10. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, et al. (2002) Psycological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf.) 57: 577-85.
11. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS, (2007) Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 17: 249-58.
12. Regalbuto C, Scollo G, Pandini G, Ferrigno R, Pezzino V, (2010) Effects of prophylaxis with iodised salt in an area of endemic goitre in north-eastern Sicily. J Endocrinol Invest 33: 300-5.
13. Davey R, (1997) Thyroxine, thyrotropin, and age in a euthyroid hospital patient population. Clin Chem 43: 2143-8.
14. Kratzsch J, Fiedler GM, Leichtle A, Brügel M, Buchbinder S, et al. (2005) New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 51: 1480-6.
15. Fadeyev VV, Morgunova TB, Sytch JP, Melnichenko GA, (2005) TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine. Hormones (Athens) 4: 101-7.
16. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L, (2006) Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91: 2592-9.
17. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, et al. (2005) Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153: 747-53.
18. Ma C, Xie J, Huang X, Wang G, Wang Y, et al. (2009) Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 30: 586-93.
19. Nygaard B, Jensen EW, Kvetny J, Jarløv A, Faber J, (2009) Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol 161: 895-902.
20. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, et al. (2009) Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 94: 1623-9.
21. Jonklaas J, Davidson B, Bhagat S, Soldin SJ, (2008) Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299: 769-77.
22. Cooper DS, (2008) Thyroxine monotherapy after thyroidectomy: coming full circle. JAMA 299: 817-9.
23. Köhrle J, Jakob F, Contempré B, Dumont JE, (2005) Selenium, the thyroid, and the endocrine system. Endocr Rev 26: 944-84.
24. De Jong FJ, Peeters RP, Den Heijer T, Van der Deure WM, Hofman A, et al. (2007) The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92: 636-40.
25. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, et al. (2008) A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93: 3075-81.
26. Visser TJ, van Buuren JC, Rutgers M, Eelkman Rooda SJ, de Herder WW, (1990) The role of sulfation in thyroid hormone metabolism. Trends Endocrinol Metab 1: 211-8.
27. Bianco AC, Kim BW, (2006) Deiodinases: implications of the local control of thyroidhormone action. J Clin Invest 116: 2571-9.
28. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR, (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89.
29. Wiersinga WM, (2001) Thyroid hormone replacement therapy. Horm Res 56 (Suppl 1): 74-81.
30. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP, (2004) Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 14: 271-5.
31. Acosta BM, Bianco AC, (2010) New insights into thyroid hormone replacement therapy. F1000 Med Rep May 11; 2 pii: 34.